Paul Tudor Jones Madrigal Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 3,400 shares of MDGL stock, worth $727,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,400
Previous 3,258
4.36%
Holding current value
$727,260
Previous $870,000
9.43%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MDGL
# of Institutions
298Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$532 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$440 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$422 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$410 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$396 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.66B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...